GBM, IDH-wildtype, is defined molecularly by any number of its hallmark changes, particularly a TERT promoter mutation, EGFR amplification (sometimes EGFRvIII), and the +7/−10 chromosome signature. Here, EGFR is linked to glioblastoma.